title: Longitudinal evaluation of airway function 21 years after preterm birth.
abstract: BACKGROUND
  There are limited longitudinal data about respiratory morbidity and lung function after preterm birth into adulthood.
  
  
  OBJECTIVE
  To determine the evolution of respiratory symptoms, spirometry, and airway hyperresponsiveness of ex-preterm subjects from childhood into adulthood.
  
  
  METHODS
  Ex-preterm subjects (median birth weight, 1,440 g; median gestation, 31.5 wk), recruited at birth (not treated with surfactant), had excess respiratory symptoms, airway obstruction, and increased airway hyperresponsiveness in mid-childhood. At a median age of 21.7 years, 60 of these subjects (the index study group) and 50 healthy term control subjects were recruited to determine respiratory morbidity and spirometry.
  
  
  RESULTS
  Respiratory symptom questionnaire, spirometry, and methacholine challenge test. The index study group had significantly more respiratory symptoms (16 of 60) than did control subjects (4 of 50) (odds ratio, 4.2; 95% confidence interval, 1.3 to 13.5; P = 0.01), but no significant difference in measured spirometry. Specifically, in the index study group and control subjects, the mean z scores (95% confidence interval of the group difference) for the FEV(1) were -0.60 and -0.58 (-0.44 to 0.49), respectively (P = 0.92); for the forced mid-expiratory flow they were -1.02 and -0.86 (-0.33 to 0.64), respectively (P = 0.52); and for the FVC they were -0.29 and -0.33 (-0.46 to 0.38), respectively (P = 0.85). Ex-preterm adults did not show evidence of increased airway hyperresponsiveness compared with control subjects, 23 and 19%, respectively (P = 0.89).
  
  
  CONCLUSIONS
  There are still excess respiratory symptoms 21 years after preterm birth. Reassuringly, this longitudinal study did not show evidence of persistent airway obstruction or airway hyperresponsiveness in ex-preterm adults.
authors.affiliation: Department of Paediatric Respiratory Medicine, Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK.
authors.forename: Indra
authors.initials: I
authors.lastname: Narang
authors.forename: Mark
authors.initials: M
authors.lastname: Rosenthal
authors.forename: David
authors.initials: D
authors.lastname: Cremonesini
authors.forename: Mike
authors.initials: M
authors.lastname: Silverman
authors.forename: Andrew
authors.initials: A
authors.lastname: Bush
mesh_terms: D000328:Adult; D016535:Bronchial Hyperreactivity / Q000175:diagnosis; D002648:Child; D005260:Female; D005500:Follow-Up Studies; D005541:Forced Expiratory Volume; D006801:Humans; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D019102:Infant, Very Low Birth Weight; D008297:Male; D008450:Maximal Midexpiratory Flow Rate; D011247:Pregnancy; D047928:Premature Birth; D012129:Respiratory Function Tests; D012140:Respiratory Tract Diseases / Q000175:diagnosis*; D012907:Smoking; D013147:Spirometry; D014797:Vital Capacity